• FirefoxInstall the new Firefox »
  •  Dow Down 0.76% Nasdaq Down 0.37%

    Exelixis, Inc. (EXEL)

    -NasdaqGS
    3.06 Up 0.06(2.00%) 2:19PM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:3.00
    Open:2.98
    Bid:3.06 x 18700
    Ask:3.07 x 3200
    1y Target Est:2.50
    Beta:1.56
    Earnings Date:Apr 29 - May 4 (Est.)
    Day's Range:2.97 - 3.10
    52wk Range:1.26 - 7.58
    Volume:2,106,648
    Avg Vol (3m):3,815,980
    Market Cap:597.36M
    P/E (ttm):N/A
    EPS (ttm):-1.38
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for EXEL

    Comparison

    Symbol% ChgMkt Cap
    EXELUp 2.00%597.36M
    AZNDown 0.62%85.70B
    GSKUp 0.31%115.13B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):23.32
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.86
    Quarterly EPS Est (Mar-15) :-0.25
    Mean Recommendation*:2.6
    PEG Ratio (5 yr expected):0.14

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Exelixis, Inc., a biopharmaceutical company, develops small molecule therapies for the treatment of cancer in the United States. The company focuses primarily on developing and commercializing COMETRIQ, an inhibitor of multiple receptor tyrosine k... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback